PMC:7105881 / 48002-48245 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1532","span":{"begin":150,"end":163},"obj":"Disease"}],"attributes":[{"id":"A1532","pred":"tao:has_database_id","subj":"1532","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In general, these subunit vaccines have strong immunogenicity and are capable of inducing high neutralizing antibodies and/or protection against MERS-CoV infection (Ma et al., 2014b; Zhang et al., 2016; Tai et al., 2017; Wang Y. et al., 2017)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T251","span":{"begin":154,"end":163},"obj":"Disease"}],"attributes":[{"id":"A251","pred":"mondo_id","subj":"T251","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"In general, these subunit vaccines have strong immunogenicity and are capable of inducing high neutralizing antibodies and/or protection against MERS-CoV infection (Ma et al., 2014b; Zhang et al., 2016; Tai et al., 2017; Wang Y. et al., 2017)."}

{"project":"2_test","denotations":[{"id":"32265848-25640653-36511199","span":{"begin":197,"end":201},"obj":"25640653"},{"id":"32265848-27795425-36511200","span":{"begin":215,"end":219},"obj":"27795425"},{"id":"32265848-28277821-36511201","span":{"begin":237,"end":241},"obj":"28277821"}],"text":"In general, these subunit vaccines have strong immunogenicity and are capable of inducing high neutralizing antibodies and/or protection against MERS-CoV infection (Ma et al., 2014b; Zhang et al., 2016; Tai et al., 2017; Wang Y. et al., 2017)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T268","span":{"begin":0,"end":243},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In general, these subunit vaccines have strong immunogenicity and are capable of inducing high neutralizing antibodies and/or protection against MERS-CoV infection (Ma et al., 2014b; Zhang et al., 2016; Tai et al., 2017; Wang Y. et al., 2017)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T760","span":{"begin":47,"end":61},"obj":"BV_15"},{"id":"T761","span":{"begin":108,"end":118},"obj":"GO:0042571"},{"id":"T762","span":{"begin":145,"end":153},"obj":"SP_9"},{"id":"T4614","span":{"begin":47,"end":61},"obj":"BV_15"},{"id":"T22946","span":{"begin":108,"end":118},"obj":"GO:0042571"},{"id":"T84916","span":{"begin":145,"end":153},"obj":"SP_9"}],"text":"In general, these subunit vaccines have strong immunogenicity and are capable of inducing high neutralizing antibodies and/or protection against MERS-CoV infection (Ma et al., 2014b; Zhang et al., 2016; Tai et al., 2017; Wang Y. et al., 2017)."}